Vistagen Faces Investor Lawsuit After Failed Drug Trial Crashes Stock

South San Francisco, Tuesday, 20 January 2026.
A class action lawsuit alleges Vistagen misled investors regarding its PALISADE-3 trial, causing significant financial damage as shares plummeted over 80% following the study’s failure.